KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/14/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization266,304 mln
Float8.43 mln
Earnings Date07/23/2025
EPS
4,923
Exceptional
P / E
3.69
Deeply undervalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.51
Likely reliable
Relative Strength
81
/ 100
Strongly outperforming
Debt / Equity
0.03
Debt-free
Business Description
Founded in 1987 and based in Seoul, Korea United Pharm develops and sells a broad range of medicines covering conditions from heart disease and cancer to allergies and digestive disorders. The company serves both prescription and over-the-counter markets, reaching customers in around 40 countries worldwide.
